Nasopharyngeal carcinoma (NPC) is a highly occurring malignant tumor in China, and about three-quarters of patients are locally advanced when diagnosed. Radiotherapy and systemic chemotherapy are currently important treatments for patients with NPC, and the prognosis of patients is not optimistic. Therefore, improving the prognosis of NPC patients is an urgent problem to be solved clinically. Recently, the latest research has found that a new regulatory cell death mode - "cuprotosis